13.34
-0.54 (-3.89%)
| Penutupan Terdahulu | 13.88 |
| Buka | 13.35 |
| Jumlah Dagangan | 1,008,818 |
| Purata Dagangan (3B) | 1,602,772 |
| Modal Pasaran | 1,494,178,560 |
| Harga / Buku (P/B) | 2.39 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 May 2026 |
| EPS Cair (TTM) | -1.88 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.97% |
| Nisbah Semasa (MRQ) | 12.00 |
| Aliran Tunai Operasi (OCF TTM) | -115.01 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -68.48 M |
| Pulangan Atas Aset (ROA TTM) | -30.87% |
| Pulangan Atas Ekuiti (ROE TTM) | -48.45% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Oric Pharmaceuticals, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.00 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 7.93% |
| % Dimiliki oleh Institusi | 102.70% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Column Group Llc | 31 Dec 2025 | 3,540,777 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 25.00 (HC Wainwright & Co., 87.41%) | Beli |
| 25.00 (Wells Fargo, 87.41%) | Beli | |
| Median | 22.00 (64.92%) | |
| Rendah | 17.00 (Citigroup, 27.44%) | Beli |
| Purata | 21.80 (63.42%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 11.89 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 24 Feb 2026 | 17.00 (27.44%) | Beli | 13.42 |
| HC Wainwright & Co. | 24 Feb 2026 | 25.00 (87.41%) | Beli | 13.42 |
| Wedbush | 24 Feb 2026 | 20.00 (49.93%) | Beli | 13.42 |
| 13 Jan 2026 | 20.00 (49.93%) | Beli | 10.14 | |
| Piper Sandler | 07 Jan 2026 | 22.00 (64.92%) | Beli | 8.68 |
| Wells Fargo | 08 Dec 2025 | 25.00 (87.41%) | Beli | 10.52 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| PISCITELLI DOMINIC | - | 13.42 | -52,000 | -697,840 |
| Jumlah Keseluruhan Kuantiti Bersih | -52,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -697,840 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 13.42 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| PISCITELLI DOMINIC | Pegawai | 24 Feb 2026 | Jual automatik (-) | 52,000 | 13.42 | 697,840 |
| PISCITELLI DOMINIC | Pegawai | 24 Feb 2026 | Pelaksanaan pilihan | 52,000 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |